TDOC - Teladoc Health, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
5.75B
Enterprise Value 3
5.77B
Trailing P/E
N/A
Forward P/E 1
-71.53
PEG Ratio (5 yr expected) 1
-2.74
Price/Sales (ttm)
11.06
Price/Book (mrq)
5.78
Enterprise Value/Revenue 3
11.10
Enterprise Value/EBITDA 6
-186.19

Trading Information

Stock Price History

Beta (3Y Monthly) 1.40
52-Week Change 343.43%
S&P500 52-Week Change 315.46%
52 Week High 386.30
52 Week Low 342.08
50-Day Moving Average 376.81
200-Day Moving Average 367.38

Share Statistics

Avg Vol (3 month) 31.34M
Avg Vol (10 day) 31.28M
Shares Outstanding 572.38M
Float 71.48M
% Held by Insiders 11.25%
% Held by Institutions 1124.26%
Shares Short (Nov 15, 2019) 425.46M
Short Ratio (Nov 15, 2019) 420.86
Short % of Float (Nov 15, 2019) 436.00%
Short % of Shares Outstanding (Nov 15, 2019) 435.17%
Shares Short (prior month Oct 15, 2019) 426.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -20.15%
Operating Margin (ttm)-14.32%

Management Effectiveness

Return on Assets (ttm)-3.00%
Return on Equity (ttm)-10.36%

Income Statement

Revenue (ttm)519.56M
Revenue Per Share (ttm)7.29
Quarterly Revenue Growth (yoy)24.30%
Gross Profit (ttm)289.17M
EBITDA -30.98M
Net Income Avi to Common (ttm)-104.7M
Diluted EPS (ttm)-1.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)490.88M
Total Cash Per Share (mrq)6.78
Total Debt (mrq)464.78M
Total Debt/Equity (mrq)46.77
Current Ratio (mrq)6.55
Book Value Per Share (mrq)13.73

Cash Flow Statement

Operating Cash Flow (ttm)14.22M
Levered Free Cash Flow (ttm)29.56M